In this article, we will discuss 10 Best European Stocks to Buy According to Analysts.
When it comes to European stocks and foreign equities, billionaires and hedge fund managers often see something the broader market overlooks: value hiding in plain sight. After more than a decade of U.S. stock market dominance, driven largely by mega-cap technology, many international markets now trade at significantly lower valuations, creating what smart money increasingly views as one of the most compelling rotation opportunities in global investing.
For elite investors, this is not simply a bet against America. It is a bet on mean reversion, diversification, and price discipline. While U.S. equities have commanded premium multiples, many European companies offer lower forward price-to-earnings ratios, higher dividend yields, and globally diversified revenue streams. That kind of disconnect tends to attract investors in the mold of Warren Buffett and Seth Klarman, who have long emphasized buying quality businesses when sentiment is subdued.
Europe also offers a roster of world-class corporate champions that many investors underestimate. Many European companies dominate their industries globally, yet often trade at valuations below comparable U.S. peers. For hedge funds, that combination of quality and relative affordability can be difficult to ignore.
There is also a growing risk-management case for looking abroad. Investors like Ray Dalio have long argued that geographic diversification matters, especially when U.S. indexes become increasingly concentrated in a handful of names. Foreign stocks can provide exposure to different economic cycles, currencies, and sector mixes.
The bottom line? European and international stocks may lack the glamour of Silicon Valley, but they offer something many crowded U.S. trades no longer do: attractive valuations, income potential, and room for rerating. For hedge funds seeking the next rotation, that opportunity is becoming harder to dismiss.
With this context in mind, here is a list of some of the best European stocks to buy now.
Our Methodology
We used screeners to identify the largest European stocks by their market capitalization, and limited our final selection to companies that have recently reported noteworthy developments likely to impact investor sentiment. These stocks are also popular among analysts and elite hedge funds.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 498.7% since May 2014, beating its benchmark by 303 percentage points (see more details here).
10 Best European Stocks to Buy According to Analysts
Rio Tinto Group (NYSE:RIO)
On April 13, Citi raised its price target on Rio Tinto Group (NYSE:RIO) to 7,200 GBp from 7,000 GBp while maintaining a Neutral rating.
Just days earlier, on April 10, Morgan Stanley analyst Alain Gabriel also lifted his target on Rio Tinto Group (NYSE:RIO) to 6,900 GBp from 6,330 GBp and kept an Equal Weight rating. While both firms stopped short of outright bullish calls, the target increases are notable because they reflect improving expectations for one of the world’s premier mining companies amid resilient commodity demand and long-term structural needs for metals tied to electrification, infrastructure, and industrial growth.
Rio Tinto Group (NYSE:RIO) is one of the most diversified mining groups globally, with operations spanning iron ore, copper, aluminum, lithium, and other critical minerals. Headquartered in London and operating as a dual-listed company with Rio Tinto plc in London and Rio Tinto Ltd in Melbourne, the company traces its origins to 1873. Its scale, geographic diversity, and low-cost asset base have made it one of the most durable names in the global resources sector.
What makes Rio Tinto Group (NYSE:RIO) especially compelling as an investment is the quality of its assets. The company owns world-class iron ore operations that generate substantial cash flow, while also expanding exposure to copper and lithium—two metals increasingly central to electric vehicles, renewable energy grids, and battery storage. This gives Rio Tinto a blend of current income power and future-facing growth potential, ranking it among the best European stocks to buy according to analysts.
9. Unilever PLC (NYSE:UL)
On April 14, Bank of America reinstated coverage of Unilever PLC (NYSE:UL) with a Buy rating and a 5,300 GBp price target. The bank’s constructive stance was driven by the company’s successful repositioning in the United States toward faster-growing wellbeing and personal care categories, its dominant competitive position in India, and a valuation it now views as compelling.
Earlier, on April 9, DZ Bank analyst Axel Herlinghaus upgraded Unilever PLC (NYSE:UL) to Buy from Hold with a 5,250 GBp target, adding to improving sentiment surrounding the shares. These analyst upgrades are significant because Unilever has traditionally been viewed as a dependable but slower-growth consumer staples business. When multiple firms simultaneously emphasize transformation initiatives, exposure to higher-growth emerging markets, and valuation upside, it often suggests that earnings momentum may be improving more meaningfully than the market had previously anticipated.
Unilever PLC (NYSE:UL), officially established in 1930 and headquartered in London, is one of the world’s largest fast-moving consumer goods companies. Its brand portfolio includes Dove, Knorr, Rexona, Magnum, Hellmann’s, and Lifebuoy. The company operates through four principal divisions: Beauty & Wellbeing, Personal Care, Home Care, and Foods.
Unilever PLC (NYSE:UL) appears attractive for long-term investors because it combines defensive consumer staples characteristics with improving growth prospects. Its shift toward premium personal care and wellbeing categories can support stronger margins, while leadership in India offers exposure to one of the world’s most compelling consumer growth markets. With valuation still seen as reasonable by analysts and sentiment turning more positive, Unilever may offer a balanced combination of resilience, income potential, and upside re-rating potential.
8. Chubb Limited (NYSE:CB)
On April 14, Bank of America lowered the firm’s price target on Chubb Limited (NYSE:CB) to $271 from $286 while maintaining an Underperform rating. The revision reflected adjustments across its U.S. insurance coverage universe tied to fourth-quarter events and changes in peer valuation multiples.
On April 8, Barclays PLC raised its price target on Chubb Limited (NYSE:CB) to $374 from $339 and maintained an Equal Weight rating. As part of a broader insurance sector preview, the firm noted that premium growth and broker organic growth are likely to remain sluggish. However, Barclays also highlighted solid margins and strong capital deployment, which should continue supporting reported book value growth.
Chubb Limited (NYSE:CB) is a global provider of insurance products, including property and casualty, accident and health, reinsurance, and life insurance. It is the world’s largest publicly traded property and casualty insurer, operating in 54 countries and territories. The company is incorporated in Zürich, with corporate roots dating back to 1792.
Chubb Limited (NYSE:CB) is among the best European stocks to buy according to analysts because even cautious analyst commentary acknowledges the company’s strong profitability and disciplined capital allocation. In insurance, consistent book value growth and underwriting margins are critical long-term value drivers. Chubb’s scale, global diversification, and conservative balance sheet position it well to navigate slower premium growth while still compounding shareholder value through pricing discipline, buybacks, and efficient deployment of capital.
7. Banco Bilbao Vizcaya Argentaria, S.A. (NYSE:BBVA)
On April 16, JPMorgan Chase & Co. raised the firm’s price target on Banco Bilbao Vizcaya Argentaria, S.A. (NYSE:BBVA) to EUR 23.60 from EUR 23.30 and maintained an Overweight rating on the shares.
On March 10, JPMorgan had previously lowered its price target on Banco Bilbao Vizcaya Argentaria, S.A. (NYSE:BBVA) to EUR 23.30 from EUR 23.50 while still maintaining an Overweight rating. The subsequent upward revision suggests analyst confidence has improved following updated assumptions or stronger operating trends.
Banco Bilbao Vizcaya Argentaria, S.A. (NYSE:BBVA) is a leading Spanish multinational financial services group founded in 1857. Headquartered in Bilbao, with operating headquarters in Madrid, the bank provides retail, corporate, and investment banking services with a strong digital focus across Spain, Mexico, Turkey, and South America.
Banco Bilbao Vizcaya Argentaria, S.A. (NYSE:BBVA) may appeal to investors seeking international banking exposure because the reaffirmed Overweight stance indicates continued confidence in earnings power and valuation. Its geographic diversification provides access to faster-growing emerging markets, particularly Mexico, while its digital banking capabilities can improve efficiency and customer retention. If interest rates remain supportive and credit quality stays stable, BBVA could continue generating attractive returns on capital.
6. Novo Nordisk A/S (NYSE:NVO)
On April 17, Citigroup Inc. lowered the firm’s price target on Novo Nordisk A/S (NYSE:NVO) to DKK 275 from DKK 309 while maintaining a Neutral rating on the shares. Although the target was reduced, the continued coverage reflects ongoing institutional focus on one of the global leaders in diabetes and obesity treatment.
The same day, market data reported mixed options sentiment in Novo Nordisk A/S (NYSE:NVO) shares, with call activity exceeding put volume and a put/call ratio below typical levels. Implied volatility moderated but remained above its 52-week median, while downside hedging demand increased. This combination suggests investors remain actively engaged in the stock while balancing optimism with near-term caution ahead of future catalysts.
Novo Nordisk A/S (NYSE:NVO) is a global healthcare company specializing in the research, development, and manufacturing of pharmaceutical products, with a primary focus on treating diabetes and obesity. It is headquartered in Bagsværd, Denmark, and was founded in 1923.
Novo Nordisk A/S (NYSE:NVO) remains a compelling long-term healthcare investment because short-term valuation resets do little to change the structural growth opportunity in obesity and diabetes care. Sixth among the 10 best European stocks to buy according to analysts, the company commands leading brands, deep research expertise, and global scale in markets that continue expanding rapidly. While analyst targets may fluctuate, long-duration demand trends and continued innovation can support sustained earnings growth over time.
While we acknowledge the potential of NVO as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than NVO and that has 100x upside potential, check out our report about the cheapest AI stock.
Click to continue reading and see the 5 Best European Stocks to Buy According to Analysts.
Disclosure: None. Follow Insider Monkey on Google News.
